2017 Fiscal Year Final Research Report
Development of new therapeutic agents targeting IL-8/CXCR2 network for esophageal squamous cell carcinoma
Project/Area Number |
16K19954
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Digestive surgery
|
Research Institution | Keio University |
Principal Investigator |
INOUE MASAZUMI 慶應義塾大学, 医学部(信濃町), 助教 (10627136)
|
Research Collaborator |
TAKEUCHI Hiroya
MATSUDA Sachiko
|
Project Period (FY) |
2016-04-01 – 2018-03-31
|
Keywords | 食道扁平上皮癌 / ケモカイン / IL-8 / CXCR2 |
Outline of Final Research Achievements |
In this study, we demonstrated that a positive IL-8 and CXCR2 expression correlates significantly with a lower recurrence-free survival rate and overall survival rate in our esophageal squamous cell carcinoma (ESCC) patient population. These results suggest that IL-8/CXCR2 expression in ESCC has a direct impact on the cellular kinetics of ESCC. In vivo, Both internal and external stimulation or inhibition of the IL-8/CXCR2 network resulted in significant enhancement or suppression of cell proliferation in ESCC cell line. In vivo, stimulation or inhibition of the IL-8/CXCR2 network also resulted in enhancement or suppression of ESCC tumor proliferation. Our results demonstrated that stimulation of the IL-8/CXCR2 network clearly enhanced ESCC cell proliferation, while its inhibition obviously suppressed ESCC cell proliferation in vitro. These results indicate that control of IL-8/CXCR2 network signaling may be a new therapeutic strategy for ESCC.
|
Free Research Field |
消化器外科学
|